Reuters: “The final clinical results of the corona vaccine in Russia will be announced as soon as possible”

Russia plans to release some of the results of the final clinical trial of the Corona 19 vaccine'Sputnik V', which was developed and approved by Russia, next month, Reuters reported.

According to Reuters, Russia will release the initial results of the Sputnik V phase 3 clinical trial as early as next month.

Dennis Rogunov, deputy director of the Gamalea National Center for Infectious Diseases and Microbiology, which developed the vaccine, said data from 50 to 10,000 clinical participants could be included in the results to be released next month.

Russia will deliver clinical trial data to India on a weekly basis, with at least 300 million Sputnik V being produced in India.

Kiril Dmitryev, president of RDIF, a Russian sovereign wealth fund that supported the development of Sputnik V, said, "We will produce Sputnik V in Korea, India, Brazil and China," at a video seminar on cooperation with South Americans. Said.